This interview examines treatment-related cardiotoxicity and the risk of second malignancy in patients with Hodgkin lymphoma.
Flora van Leeuwen, PhD
Advertisement
Articles by Flora van Leeuwen, PhD
Advertisement
Latest Updated Articles
Late Toxicity of Radiotherapy and Chemotherapy in Hodgkin LymphomaPublished: December 9th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
